192 related articles for article (PubMed ID: 18004887)
1. A disease state mutation unfolds the parkin ubiquitin-like domain.
Safadi SS; Shaw GS
Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
[TBL] [Abstract][Full Text] [Related]
2. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
[TBL] [Abstract][Full Text] [Related]
3. Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.
Safadi SS; Barber KR; Shaw GS
Biochemistry; 2011 Apr; 50(13):2603-10. PubMed ID: 21348451
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.
Safadi SS; Shaw GS
J Biol Chem; 2010 Jan; 285(2):1424-34. PubMed ID: 19875440
[TBL] [Abstract][Full Text] [Related]
5. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin.
Tomoo K; Mukai Y; In Y; Miyagawa H; Kitamura K; Yamano A; Shindo H; Ishida T
Biochim Biophys Acta; 2008; 1784(7-8):1059-67. PubMed ID: 18485927
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
Beasley SA; Hristova VA; Shaw GS
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
[TBL] [Abstract][Full Text] [Related]
8. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
Hristova VA; Beasley SA; Rylett RJ; Shaw GS
J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
[TBL] [Abstract][Full Text] [Related]
10. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
Biswas S; Roy R; Biswas R; Bagchi A
Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
[TBL] [Abstract][Full Text] [Related]
13. Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation.
Condos TE; Dunkerley KM; Freeman EA; Barber KR; Aguirre JD; Chaugule VK; Xiao Y; Konermann L; Walden H; Shaw GS
EMBO J; 2018 Dec; 37(23):. PubMed ID: 30446597
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
[TBL] [Abstract][Full Text] [Related]
15. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
16. Activation of the E3 ubiquitin ligase Parkin.
Caulfield TR; Fiesel FC; Springer W
Biochem Soc Trans; 2015 Apr; 43(2):269-74. PubMed ID: 25849928
[TBL] [Abstract][Full Text] [Related]
17. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
Nat Commun; 2013; 4():1983. PubMed ID: 23770917
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity.
Kazlauskaite A; Kelly V; Johnson C; Baillie C; Hastie CJ; Peggie M; Macartney T; Woodroof HI; Alessi DR; Pedrioli PG; Muqit MM
Open Biol; 2014 Mar; 4(3):130213. PubMed ID: 24647965
[TBL] [Abstract][Full Text] [Related]
19. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
20. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
